Treatments: Thyroid Nodules

This page describes how thyroid nodules are monitored and treated, from ultrasound surveillance to surgery and ablation.

Most thyroid nodules are benign (not cancer), and many never need to be removed. The approach depends on how the nodule looks on ultrasound, what a biopsy shows, whether the nodule is causing symptoms and whether it is making too much thyroid hormone. This page describes the main treatment and monitoring options. The condition itself is described on the thyroid nodules conditions page.

Watching the Nodule Over Time (Ultrasound Surveillance)

When a nodule looks low-risk on ultrasound (see TI-RADS scoring) and a biopsy shows benign cells, the usual plan is to keep an eye on it rather than treat it. Monitoring is done with a neck ultrasound, not surgery.

• A repeat ultrasound is often done about 12 to 24 months after the first biopsy.

• If the nodule is stable, the time between ultrasounds can be stretched to every 2 to 5 years.

• Nodules with more suspicious ultrasound features, or that cause symptoms, may be checked sooner (for example, every 6 to 12 months).

• A nodule is considered to have grown meaningfully if its volume increases by more than 50%, or if it grows by at least 20% in two or more measurements (by at least 2 mm). Meaningful growth, new worrisome features or new symptoms may prompt a repeat biopsy.

Benign nodules usually do not need thyroid hormone pills as "treatment," and hormone medication is not used simply to shrink a benign nodule in someone whose thyroid is working normally.

When Biopsy Results Are "Indeterminate"

A fine-needle biopsy sometimes cannot clearly say whether a nodule is benign or cancer. These "indeterminate" results (often called Bethesda III or Bethesda IV; see the Bethesda system) carry a moderate chance of cancer, so extra steps can help avoid surgery that may not be needed.

• Repeat biopsy: A second fine-needle aspiration may be done, sometimes 6 to 12 months later, to try to get a clearer answer.

• Molecular (genetic) testing: The biopsy sample can be tested for genetic changes linked to thyroid cancer. Widely used tests include ThyroSeq, Afirma and ThyGeNEXT/ThyraMIR. These tests are very good at ruling cancer out: a "negative" or "benign" result means the chance of cancer is low, and many patients can then be monitored instead of having surgery. A "positive" or "suspicious" result raises the concern for cancer and often leads to surgery. Results are always weighed together with the ultrasound findings and the patient's history.

• Diagnostic surgery: In some situations, removing the nodule (usually with a lobectomy) is the clearest way to get a final diagnosis.

Surgery: Lobectomy Versus Total Thyroidectomy

Surgery is the standard treatment when a nodule is cancer or strongly suspected to be cancer (see treatment of thyroid cancer or suspected cancer), and it is sometimes chosen for large or symptomatic nodules. There are two main operations, compared further on the extent of thyroid surgery page.

• Thyroid lobectomy removes only the half of the thyroid that contains the nodule. It provides a tissue diagnosis, carries a lower risk of complications, and often preserves enough thyroid function that lifelong thyroid hormone pills are not needed (about half of patients). The main trade-offs are that a second operation may later be needed if cancer is found, and some patients still develop an underactive thyroid afterward.

• Total thyroidectomy removes the entire thyroid gland. It is generally preferred for larger nodules (usually greater than 4 cm), cancer that extends beyond the thyroid or has spread, nodules in both lobes, or certain high-risk situations such as prior radiation to the neck or a family history of thyroid cancer. Because the whole gland is removed, lifelong thyroid hormone replacement is required (see treatment of hypothyroidism).

Risks of surgery are generally low, especially with an experienced surgeon, but are higher with total thyroidectomy than with lobectomy. They include:

• Temporary or, less often, permanent hoarseness or voice change from injury to a nerve near the thyroid.

• Low calcium levels from effects on the nearby parathyroid glands; more common after total thyroidectomy, usually temporary but occasionally permanent.

• Bleeding and, rarely, infection.

Recovery after thyroid surgery is usually quick; many people go home the same day or after one night and return to normal activities within a week or two, with some neck stiffness or tenderness at first. More detail is on the thyroidectomy recovery page and in the thyroidectomy surgery packet.

Minimally Invasive Ablation for Benign Nodules

For benign nodules that cause symptoms, such as a visible lump, pressure or discomfort, ablation can shrink the nodule without removing the thyroid. These are needle-based procedures done through the skin using ultrasound guidance, usually without a surgical incision and often as an outpatient.

• Radiofrequency ablation (RFA) uses heat delivered through a thin probe to shrink the nodule. It is the most studied heat-based option and reliably reduces nodule size over months, with substantial shrinkage by 6 to 12 months and continued shrinkage over the following years, along with improvement in symptoms and appearance. Compared with surgery for benign nodules, RFA has fewer complications and is more likely to preserve normal thyroid function. Other heat-based methods include microwave ablation and laser ablation.

• Recovery and risks: Most people resume normal activity quickly. The nodule shrinks gradually rather than disappearing immediately, and some nodules partly regrow over time and may need a repeat session. Possible side effects include temporary pain, bruising and, uncommonly, temporary voice change.

Ethanol (Alcohol) Ablation for Cystic Nodules

Nodules that are mostly fluid-filled (cystic) respond especially well to ethanol ablation, in which fluid is drained and a small amount of alcohol is injected to collapse the cyst. It is simple, effective for cystic and mostly cystic nodules, and is often the preferred ablation method for these. For nodules that are more solid, heat-based ablation such as RFA tends to work better.

Radioactive Iodine for Overactive ("Hot") Nodules

Some nodules make too much thyroid hormone, causing an overactive thyroid (hyperthyroidism). These "hot" or autonomously functioning nodules are very rarely cancer. A common treatment is radioactive iodine, taken by mouth, which is absorbed mainly by the overactive nodule and reduces its hormone production over weeks to months.

• If radioactive iodine is not suitable or not preferred, anti-thyroid medication can control the overactive thyroid, and surgery is another option once hormone levels are controlled. See treatments for hyperthyroidism.

• After radioactive iodine, thyroid blood tests are followed over time, because the thyroid can become underactive and require hormone replacement.

• Radioactive iodine is not used during pregnancy or breastfeeding, and brief precautions to limit close contact with others may apply afterward.

Follow-Up After Treatment

• After monitoring or ablation of a benign nodule: periodic ultrasound to track size and check for regrowth.

• After lobectomy: blood tests to confirm the remaining thyroid is making enough hormone; some patients need hormone pills.

• After total thyroidectomy: lifelong thyroid hormone replacement with periodic blood tests to adjust the dose.

• After radioactive iodine: periodic blood tests to monitor thyroid function.

Questions Often Discussed With the Care Team

• Is this nodule benign, cancer or still uncertain?

• Does this nodule actually need treatment, or is monitoring reasonable?

• If treatment is needed, which options fit this specific nodule?

• What are the risks, recovery time and chance of needing thyroid hormone pills afterward?

• How often will follow-up ultrasounds or blood tests be needed?